| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Scientometrics |
| Article Title |
Immune cells in metabolic associated fatty liver disease: Global trends and hotspots (2004-2024)
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Ying Qi, Shi-Hao Zheng, Si-Ze Li, Wei Wang, Qiu-Yue Wang, Qi-Yao Liu, Xiao-Ke Li, Jia-Xin Zhang, Da-Nan Gan, Yong-An Ye and Xiao-Bin Zao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Horizontal Project of Dongzhimen Hospital |
No. HX-DZM-202343 |
|
| Corresponding Author |
Xiao-Bin Zao, Department of Spleen and Stomach Diseases, Dongzhimen Hospital of Beijing University of Chinese Medicine, No. 5 Haiyuncang Road, Dongcheng District, Beijing 100700, China. a3417@bucm.edu.cn |
| Key Words |
Bibliometrics; Global research effort; Immune cells; Metabolic associated fatty liver disease; Research trends |
| Core Tip |
This study provides a comprehensive bibliometric analysis of global trends and hotspots in research on immune cells and metabolic associated fatty liver disease from 2004 to 2024. It highlights key proteins (e.g., interleukin-6, tumor necrosis factor, signal transducer and activator of transcription 3) and potential therapeutic targets identified through bioinformatics, emphasizing the critical roles of oxidative stress, metabolic syndrome, and Kupffer cells in metabolic associated fatty liver disease pathogenesis. The findings offer a roadmap for future research and clinical strategies to address this growing health challenge. |
| Publish Date |
2025-03-26 04:06 |
| Citation |
<p>Qi WY, Zheng SH, Li SZ, Wang W, Wang QY, Liu QY, Li XK, Zhang JX, Gan DN, Ye YA, Zao XB. Immune cells in metabolic associated fatty liver disease: Global trends and hotspots (2004-2024). <i>World J Hepatol</i> 2025; 17(3): 103327</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i3/103327.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i3.103327 |
